Founder And Ceo
CurrentClinical Drug Development of Immunotherapies for the Treatment of Neurodegenerative Diseases and Cancers
Please complete the CAPTCHA to continue
@augustusbiotarget.com
✓
LinkedIn matched
A concise factual answer block for searchers comparing this professional profile.
Michael Scolaro is listed as Founder and CEO at Augustus BioTarget, Inc., based in Myrtle Beach, South Carolina, United States. AeroLeads shows a work email signal at augustusbiotarget.com and a matched LinkedIn profile for Michael Scolaro.
Michael Scolaro previously worked as Medical Consultant and Co-Founder at Rodos Biotarget Gmbh and Director, Founder at Let There Be Hope Med. Res. Institute. Michael Scolaro holds Doctor Of Medicine (M.D.), Medicine from Michael Scolaro -Busm.
This section adds company-level context without repeating Michael Scolaro's masked contact details.
AeroLeads found 1 current-domain work email signal for Michael Scolaro. Compare company email patterns before reaching out.
We are seeking equity funding for the development of a novel treatment for Alzheimer's disease. We are employing our proprietary nanocarrier that targets migratory cells of the immune system which cross the Blood Brain Barrier and transport our therapeutics to diseased areas of the brain to correct two fundamental pathological features of this disease, abnormal protein tau and amyloid beta aggregation.Subsequent to our initial clinical and preclinical development for which this funding is being sought, this same approach will be applied to other neurodegenerative diseases, namely, Multiple Sclerosis and Parkinson Disease.Please see our website for more specific information: http://www.AugustusBioTarget.com
Listed skills include Clinical Development, Immunology, Life Sciences, Biotechnology, and 32 others.
Company context helps verify the profile and gives searchers a useful next step.
A career timeline built from the work history available for this profile.
North Myrtle Beach, South Carolina, Usa
Clinical Drug Development of Immunotherapies for the Treatment of Neurodegenerative Diseases and Cancers
Hannover Area, Germany
Co-inventor of carbohydrate labeled nanoparticle which exclusively targets C-Type Lectin Receptors on all Antigen-presenting Cells of the immune system. Preclinical and clinical development in collaboration with academic and industrial affiliates.
Beverly Hills, Ca
Developed techniques for intracellular endolysosomal targeting and delivery of active pharmaceutical ingredients to Antigen-presenting Cells of the immune system, and co-invented worldwide patents for this technology with collaborating scientists.Mission: Mobilizing the immune system in the treatment of neurodegenerative diseases and cancers.Website: www.LetThereBeHope.org
Quick answers generated from the profile data available on this page.
Michael Scolaro works for Augustus BioTarget, Inc..
Michael Scolaro is listed as Founder and CEO at Augustus BioTarget, Inc..
AeroLeads has found 1 work email signal at @augustusbiotarget.com for Michael Scolaro at Augustus BioTarget, Inc..
Michael Scolaro is based in Myrtle Beach, South Carolina, United States while working with Augustus BioTarget, Inc..
Michael Scolaro has worked for Augustus Biotarget, Inc., Rodos Biotarget Gmbh, and Let There Be Hope Med. Res. Institute.
You can use AeroLeads to view verified contact signals for Michael Scolaro at Augustus BioTarget, Inc., including work email, phone, and LinkedIn data when available.
Michael Scolaro holds Doctor Of Medicine (M.D.), Medicine from Michael Scolaro -Busm.
Michael Scolaro is listed with skills including Clinical Development, Immunology, Life Sciences, Biotechnology, Molecular Biology, Clinical Research, Cancer, and Drug Development.
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial Search contactsCheck these profiles if this is not the Michael Scolaro you were looking for.